Annual Cash & Cash Equivalents
$35.85 M
-$16.30 M-31.26%
December 31, 2023
Summary
- As of February 6, 2025, INMB annual cash & cash equivalents is $35.85 million, with the most recent change of -$16.30 million (-31.26%) on December 31, 2023.
- During the last 3 years, INMB annual cash & cash equivalents has risen by +$13.88 million (+63.19%).
- INMB annual cash & cash equivalents is now -52.08% below its all-time high of $74.81 million, reached on December 31, 2021.
Performance
INMB Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Cash And Cash Equivalents
$33.55 M
+$2.48 M+7.99%
September 30, 2024
Summary
- As of February 6, 2025, INMB quarterly cash and cash equivalents is $33.55 million, with the most recent change of +$2.48 million (+7.99%) on September 30, 2024.
- Over the past year, INMB quarterly cash and cash equivalents has increased by +$2.48 million (+7.99%).
- INMB quarterly cash and cash equivalents is now -60.28% below its all-time high of $84.47 million, reached on September 30, 2021.
Performance
INMB Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash And Cash Equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
INMB Cash And Cash Equivalents Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -31.3% | +8.0% |
| 3 y3 years | +63.2% | +8.0% |
| 5 y5 years | +10000.0% | +8.0% |
INMB Cash And Cash Equivalents Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -52.1% | at low | -55.1% | +29.0% |
| 5 y | 5-year | -52.1% | +412.4% | -60.3% | +596.6% |
| alltime | all time | -52.1% | >+9999.0% | -60.3% | >+9999.0% |
INmune Bio Cash And Cash Equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $33.55 M(+8.0%) |
| Jun 2024 | - | $31.07 M(+19.5%) |
| Mar 2024 | - | $26.00 M(-27.5%) |
| Dec 2023 | $35.85 M(-31.3%) | $35.85 M(-14.3%) |
| Sep 2023 | - | $41.81 M(-12.6%) |
| Jun 2023 | - | $47.83 M(-6.2%) |
| Mar 2023 | - | $51.00 M(-2.2%) |
| Dec 2022 | $52.15 M(-30.3%) | $52.15 M(-9.1%) |
| Sep 2022 | - | $57.41 M(-6.2%) |
| Jun 2022 | - | $61.21 M(-8.3%) |
| Mar 2022 | - | $66.73 M(-10.8%) |
| Dec 2021 | $74.81 M | $74.81 M(-11.4%) |
| Sep 2021 | - | $84.47 M(+113.7%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2021 | - | $39.52 M(-12.8%) |
| Mar 2021 | - | $45.34 M(+106.4%) |
| Dec 2020 | $21.97 M(+214.0%) | $21.97 M(-9.6%) |
| Sep 2020 | - | $24.31 M(+404.7%) |
| Jun 2020 | - | $4.82 M(-18.8%) |
| Mar 2020 | - | $5.93 M(-15.2%) |
| Dec 2019 | $7.00 M(+3657.0%) | $7.00 M(-5.2%) |
| Sep 2019 | - | $7.38 M(-21.2%) |
| Jun 2019 | - | $9.36 M(+54.8%) |
| Mar 2019 | - | $6.05 M(+3148.6%) |
| Dec 2018 | $186.20 K(-86.4%) | $186.20 K(-71.4%) |
| Sep 2018 | - | $650.90 K(-52.5%) |
| Dec 2017 | $1.37 M(+867.3%) | $1.37 M |
| Dec 2016 | $141.70 K | - |
FAQ
- What is INmune Bio annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for INmune Bio?
- What is INmune Bio annual cash & cash equivalents year-on-year change?
- What is INmune Bio quarterly cash and cash equivalents?
- What is the all time high quarterly cash and cash equivalents for INmune Bio?
- What is INmune Bio quarterly cash and cash equivalents year-on-year change?
What is INmune Bio annual cash & cash equivalents?
The current annual cash & cash equivalents of INMB is $35.85 M
What is the all time high annual cash & cash equivalents for INmune Bio?
INmune Bio all-time high annual cash & cash equivalents is $74.81 M
What is INmune Bio annual cash & cash equivalents year-on-year change?
Over the past year, INMB annual cash & cash equivalents has changed by -$16.30 M (-31.26%)
What is INmune Bio quarterly cash and cash equivalents?
The current quarterly cash and cash equivalents of INMB is $33.55 M
What is the all time high quarterly cash and cash equivalents for INmune Bio?
INmune Bio all-time high quarterly cash and cash equivalents is $84.47 M
What is INmune Bio quarterly cash and cash equivalents year-on-year change?
Over the past year, INMB quarterly cash and cash equivalents has changed by +$2.48 M (+7.99%)